August 21, 2025

Nasdaq Boots Windtree a Month After $700M BNB Treasury Pivot Fails to Lift Stock

Windtree Therapeutics, a Pennsylvania-based drug developer, is being delisted from Nasdaq, just over a month after its $700 million pivot into a digital treasury firm focused on Binance’s BNB token failed to boost its stock above the exchange’s …

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright ©CashBot.Club All rights reserved. | Newsphere by AF themes.